SHEREENA SORRELL-WHITAKER: Open Payments
NPI 1598223547 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$562 in 5 payments from 5 companies in 2025. Trend: 2023 $402 · 2024 $344 · 2025 $562
Food & beverage: $562
| Company | Payments | Amount |
|---|---|---|
| Orchard Therapeutics North America | 1 | $152 |
| ARGENX US, INC. | 1 | $125 |
| Novo Nordisk Inc | 1 | $122 |
| Neurelis, Inc. | 1 | $85 |
| Chiesi USA, Inc. | 1 | $79 |
Products named: LENMELDY, VYVGART, Ozempic, VALTOCO, CLEVIPREX.
Industry payments across MD — which companies pay providers there.
